Propriétés biologiques du récepteur TLR3 dans les carcinomes des voies aérodigestives supérieures : contribution à l’oncogénèse et intérêt comme cible thérapeutique

Propriétés biologiques du récepteur TLR3 dans les carcinomes des voies aérodigestives supérieures : contribution à l’oncogénèse et intérêt comme cible thérapeutique

Contexte. Les carcinomes des voies aérodigestives supérieures (VADS) arrivent en 6ème position parmi les cancers les plus fréquents au niveau mondial. La fonction du récepteur TLR3 dans les cellules de carcinomes des VADS est encore très mal comprise. Objectifs et méthodes. 1) Déterminer le niveau d...

Full description

Bibliographic Details
Main Author:	Verillaud, Benjamin
Other Authors:	Paris 11
Language:	fr
Published:	2015
Subjects:	Récepteur Toll-like 3 Carcinome nasopharyngé Carcinomes des voies aérodigestives supérieures Immunité innée Effet Warburg HIF Étude métabolomique Virus d’Epstein-Barr Poly(A:U) Mimétique de Smac IAP Toll-like receptor 3 Nasopharyngeal cancer Head and Neck carcinoma Innate immunity Warburg effect Metabolomics Epstein-Barr virus Smac-mimetic Inhibitor of Apoptosis Protein
Online Access:	http://www.theses.fr/2015PA11T006/document

Similar Items

Expression of toll-like receptors in non-endemic nasopharyngeal carcinoma
by: Miia Ruuskanen, et al.
Published: (2019-06-01)

PREVALENCE OF POLYMORPHISM OF THE TLR-9 TYPE GENE IN PATIENTS WITH CHRONIC EPSTEIN-BARR VIRUS INFECTION
by: Lyadova T. I., et al.
Published: (2018-07-01)

Monitoring the efficacy of conservative treatment of nasopharyngeal carcinoma by examining Epstein–Barr virus DNA titers in blood plasma (review)
by: D. A. Miroshnichenko, et al.
Published: (2020-11-01)

Nasopharyngeal carcinoma with pericardial metastasis
by: Shang-Wen Chen, et al.
Published: (2011-07-01)

Carcinogenesis of nasopharyngeal carcinoma: an alternate hypothetical mechanism
by: Sharon Shuxian Poh, et al.
Published: (2016-01-01)

Toll-like receptor gene polymorphisms and susceptibility to Epstein-Barr virus-associated and -negative gastric carcinoma in Northern China
by: Shuzhen Liu, et al.
Published: (2015-01-01)

Nasopharyngeal Carcinoma Associated with Hemophagocytic Lymphohistiocytosis
by: Hsu Wu, et al.
Published: (2015-03-01)

Smoking can increase nasopharyngeal carcinoma risk by repeatedly reactivating Epstein‐Barr Virus: An analysis of a prospective study in southern China
by: Ting Hu, et al.
Published: (2019-05-01)

The Criteria to Confirm the Role of Epstein-Barr Virus in Nasopharyngeal Carcinoma Initiation
by: Ai-Di Gu, et al.
Published: (2012-10-01)

Interplay of Viral Infection, Host Cell Factors and Tumor Microenvironment in the Pathogenesis of Nasopharyngeal Carcinoma
by: Shaina Chor Mei Huang, et al.
Published: (2018-04-01)

Expression of Epstein-Barr virus proteins and their detection by IgG antibodies
by: Rosek, Alyssa
Published: (2018)

DNA Epstein-Barr virus (EBV) sebagai biomaker diagnosis karsinoma nasofaring
by: Janti Sudiono, et al.
Published: (2013-09-01)

Characterization of aberrantly expressed microRNAs in Epstein-Barr virus-associated nasopharyngeal carcinoma.
Published: (2013)

Analyse des altérations oncogéniques associées aux lymphomes NK/T de type nasal
by: Huang, Yen-Lin
Published: (2009)

A combination of two ELISA tests for nasopharyngeal carcinoma screening in endemic areas based on a case-control study
by: Dongping Rao, et al.
Published: (2020-11-01)

Individualized concurrent chemotherapy by pretreatment plasma Epstein‐Barr viral DNA in II‐III stage nasopharyngeal carcinoma: A propensity score matching analysis using a large cohort
by: Xue‐Song Sun, et al.
Published: (2019-08-01)

Emodin Inhibits EBV Reactivation and Represses NPC Tumorigenesis
by: Chung-Chun Wu, et al.
Published: (2019-11-01)

Analysis of Serum Levels of IgA Antibodies to Epstein Barr Virus Capsid Antigens in the Spouses and the Children of Patients with Nasopharyngeal Carcinoma
by: Jiru CHENG, et al.
Published: (2009-08-01)

Role of Epstein-Barr virus in the development of nasopharyngeal carcinoma
by: Zhang Hui, et al.
Published: (2017-06-01)

Immunological response of patients with nasopharyngeal carcinoma against Epstein-Barr virus-specific antigens.
Published: (2004)

Current approach and novel perspectives in nasopharyngeal carcinoma: the role of targeting proteasome dysregulation as a molecular landmark in nasopharyngeal cancer
by: Ramon Yarza, et al.
Published: (2021-06-01)

The Epstein-Barr Virus-Encoded EBNA1 Protein Activates the Bone Morphogenic Protein (BMP) Signalling Pathway to Promote Carcinoma Cell Migration
by: Hannah E. Bridgewater, et al.
Published: (2020-07-01)

Inflammations orales et infection par le virus d’Epstein-Barr : vers un nouveau paradigme en pathogenèse orale
by: Olivieri, Charles-Vivien
Published: (2018)

Lack of association between cigarette smoking and Epstein Barr virus reactivation in the nasopharynx in people with elevated EBV IgA antibody titres
by: Yufeng Chen, et al.
Published: (2018-02-01)

Implication du virus Epstein-Barr ainsi que de la protéine virale EBNA1 dans la modification de l’épissage alternatif et dans le développement du cancer de l’estomac
by: Saavedra Armero, Victoria E.
Published: (2016)

Epstein–Barr Virus DNA Exacerbates Colitis Symptoms in a Mouse Model of Inflammatory Bowel Disease
by: Sirine Andari, et al.
Published: (2021-06-01)

Sarcomatoid carcinoma of the upper aerodigestive tract: An immunohistochemical analysis demonstrating latent <i>Epstein-Barr</i> virus in a subset of eight cases
by: Etit Demet, et al.
Published: (2010-10-01)

Correlation Between Immune Function Status and EBV DNA in Patients with Nasopharyngeal Carcinoma and Their Influence on Prognosis
by: WEI Xueling, et al.
Published: (2021-06-01)

Comparing three induction chemotherapy regimens for patients with locoregionally advanced nasopharyngeal carcinoma based on TNM stage and plasma Epstein–Barr virus DNA level
by: Sai-Lan Liu, et al.
Published: (2020-02-01)

The Role of NK Cells in EBV Infection and EBV-Associated NPC
by: Yi Tian Png, et al.
Published: (2021-02-01)

Circulating cell‐free epstein–barr virus DNA levels and clinical features in Moroccan patients with nasopharyngeal carcinoma
by: Amina Gihbid, et al.
Published: (2021-02-01)

Pediatric Nasopharyngeal Carcinoma as Seen on 18F-FDG PET/CT
by: Razi Muzaffar, et al.
Published: (2019-03-01)

Genotypic Characterization of Epstein Barr Virus in Blood of Patients with Suspected Nasopharyngeal Carcinoma in Ghana
by: Richmond Ayee, et al.
Published: (2020-07-01)

Pre-emptive and therapeutic adoptive immunotherapy for nasopharyngeal carcinoma: Phenotype and effector function of T cells impact on clinical response
by: Corey Smith, et al.
Published: (2017-02-01)

Epstein-Barr Virus-Encoded Products Promote Circulating Tumor Cell Generation: A Novel Mechanism of Nasopharyngeal Carcinoma Metastasis
by: Yang Z, et al.
Published: (2020-01-01)

New Insights from Elucidating the Role of LMP1 in Nasopharyngeal Carcinoma
by: Kathy H. Y. Shair, et al.
Published: (2018-03-01)

Advances in pathogenesis and precision medicine for nasopharyngeal carcinoma
by: Qian‐Ying Zhu, et al.
Published: (2021-06-01)

Bioinformatics analyses of high-throughput genomic and transcriptomic data from nasopharyngeal carcinoma cell line, xenografts and associated Epstein-Barr virus
Published: (2014)

Current Status and Future Perspectives about Molecular Biomarkers of Nasopharyngeal Carcinoma
by: Pui Yan Siak, et al.
Published: (2021-07-01)

Progesterone analogues reduce plasma Epstein–Barr virus DNA load and improve pain control in recurrent/metastatic nasopharyngeal carcinoma patients under supportive care
by: Chia-Yen Hung, et al.
Published: (2017-08-01)